Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Sildenafil improves quality of life in men with heart failure and erectile dysfunction

Abstract

Patients with congestive heart failure (CHF) have specific factors that enhance the risk for erectile dysfunction (ED), such as low cardiac output and the use of drugs with vasodilator effect. ED can negatively affect interpersonal relationships and self-esteem, with significant impact on the quality of life. We hypothesized that the improvement of the sexual dysfunction would enhance the quality of life of individuals with systolic heart failure. This is a prospective study of 12 male CHF patients using a fixed dose of sildenafil during 1 month. Patients were included if they had left ventricular ejection fraction lower than 40% documented by echocardiography and International Index of Erectile Function (IIEF) score lower than 21. The effect of sildenafil in quality of life was evaluated by the Minnesota questionnaire. Improvement in ED was assessed using the IIEF. The mean IIEF5 score was 9.6 (±3.8) before the use of sildenafil and 19.3 (±4.3) after sildenafil (P=0.0001). The mean Minnesota score was 28.75 (±21) before treatment and 12.75 (±10.1) after the intervention (P=0.012). In conclusion, the sexual function improvement provided by sildenafil enhances quality of life in individuals with systolic heart failure.

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    CAS  Article  PubMed  Google Scholar 

  2. Moreira ED, Lisboa Lobo CF, Villa M, Nicolosi A, Glasser DB . Prevalence and correlates of erectile dysfunction in Salvador, northeastern Brazil: a population-based study. Int J Impot Res 2002; 14(Suppl 2): S3–S9.

    Article  PubMed  Google Scholar 

  3. Althof S . The patient with erectile dysfunction: psychological issues. Nurse Pract 2000; (Suppl): 11–13.

    Article  Google Scholar 

  4. Katz SD, Parker JD, Glasser DB, Bank AJ, Sherman N, Wang H et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure. Am J Cardiol 2005; 95: 36–42.

    CAS  Article  PubMed  Google Scholar 

  5. Benet AE, Melman A . The epidemiology of erectile dysfunction. Urol Clin North Am 1995; 22: 699–709.

    CAS  PubMed  Google Scholar 

  6. Hak T, Willems D, van der Wal G, Visser F . A qualitative validation of the Minnesota Living with Heart Failure Questionnaire. Qual Life Res 2004; 13: 417–426.

    Article  PubMed  Google Scholar 

  7. Rhoden EL, Teloken C, Sogari PR, Vargas Souto CA . The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res 2002; 14: 245–250.

    CAS  Article  PubMed  Google Scholar 

  8. Crapo RO, Casaburi R, Coates AL, Enright PL, MacIntyre NR, Mckay RT et al. ATS: statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117.

    Article  Google Scholar 

  9. Webster LJ, Michelakis ED, Davis T, Archer SL . Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial. Arch Intern Med 2004; 164: 514–520.

    CAS  Article  PubMed  Google Scholar 

  10. Bestetti RB, Muccilo G . Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol 1997; 60: 187–193.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D Freitas.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Freitas, D., Athanazio, R., Almeida, D. et al. Sildenafil improves quality of life in men with heart failure and erectile dysfunction. Int J Impot Res 18, 210–212 (2006). https://doi.org/10.1038/sj.ijir.3901385

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901385

Keywords

  • impotence
  • quality of life
  • heart failure
  • urologic and male genital disease

Further reading

Search

Quick links